Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Nanomedicine|February 13, 2024
Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy ResistanceTing Li, Lianshan Guo, Jiaxu Li, et al.World Journal of Surgical Oncology|May 1, 2026
The predictive value of multidimensional frailty instruments for postoperative adverse outcomes in cancer patients: a systematic review and meta-analysisYue Chen, Shulin Song, Ziyan Wang, et al.Cancer Management and Research|April 30, 2025
Prediction of Ki-67 Expression in HIV-Associated Lung Adenocarcinoma Patients Using Multiple Machine Learning Models Based on CT Imaging RadiomicsChang Song, Jingsong Chen, Chunyan Zhao, et al.BMC Geriatrics|November 7, 2025
Willingness, preference, and resistance to frailty intervention for older gastric cancer based on stakeholder perspective: a qualitative studyYinning Guo, Shulin Song, Lingyu Ding, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 13, 2025
Associations between the triglyceride glucose-body roundness index and frailty trajectory in populations with Cardiovascular-Kidney-Metabolic syndrome: A nationwide prospective cohort studyZhongmin Fu, Shulin Song, Yan Ji, et al.Scientific Reports|September 3, 2020
Accumulation of synovial fluid CD19+CD24hiCD27+ B cells was associated with bone destruction in rheumatoid arthritisXiaofeng Guo, Tingting Xu, Jing Zheng, et al.Communications Biology|November 26, 2025
Microbial influx during early postnatal life fortifies the ocular surface and guards against allergic eye disease in miceYanbo Liu, Hang Sun, Shulin Song, et al.The Lancet. Rheumatology|August 25, 2020
COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational studyJixin Zhong, Guifen Shen, Huiqin Yang, et al.Rheumatology (Oxford, England)|February 7, 2025
Comparison of the efficacy and safety of methotrexate injection and methotrexate tablets in active RALin Qiao, Jiankang Hu, Daming Ou, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 13, 2025
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients with Active Ankylosing Spondylitis: Results from an Adaptive Seamless Phase II/III TrialXu Liu, Liling Xu, Cheng Zhao, et al.Pageof 3